A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: Clinical, immunological, and epidemiological aspects

Annals of the Rheumatic Diseases

Volumn 60, Issue 5, 2001, Pages 467-472

  Pertovaara, M ^a   Pukkala, E ^b   Laippala, P ^c   Miettinen, A ^a   Pasternack, A ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BETA 2 MICROGLOBULIN; GLUCOCORTICOID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CANCER INCIDENCE; CLINICAL FEATURE; CLINICAL IMMUNOLOGY; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FINLAND; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; SJOEGREN SYNDROME;

AGED; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CAUSE OF DEATH; FEMALE; FINLAND; HUMANS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 0035023371     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.5.467     Document Type: Article

References (42)

1. Long-term follow-up of patients with Sjögren's syndrome
2. Sjögren's syndrome: A clinical, pathological and serological study of sixty-two cases
3. Increased risk of lymphoma in Sjögren's syndrome
4. Nodal and extranodal lymphoproliferative disorders in Sjögren's syndrome: A clinical and immunopathologic study
5. Development of malignant lymphoma in the course of Sjögren's syndrome
6. Clinical follow-up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both)
7. Sjögren's syndrome. Proposed criteria for classification
8. Preliminary criteria for the classification of Sjögren's syndrome: Rresults of a prospective concerted action supported by the European Community
9. Labial salivary gland biopsy in Sjögren's syndrome
10. The clinical picture of primary Sjögren's syndrome: A retrospective study
11. Primary Sjögren's syndrome in North East England: A longitudinal study
12. Primary Sjögren's syndrome: Clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology
13. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome
14. Primary Sjögren's syndrome in the North East of England: A long-term follow-up study
15. Sjögren's syndrome 2. Clinical associations and immunological phenomena
16. Hydroxychloroquine treatment for primary Sjögren's syndrome: A two year double blind crossover trial
17. Restriction of immunoglobulin heterogeneity, autoimmunity and serum protein levels in aged people
18. Antibody and immunoglobulin levels in aged humans
19. Relationship between immunoglobulin levels and specific antibody titers in the elderly
20. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population
21. Lymphoma in Sjögren's syndrome
22. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland)
23. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome
24. Primary Sjögren's syndrome (SS) and malignant lymphoma
25. Monocytoid B-cell lymphoma in patients with Sjögren's syndrome. A clinicopathologic study of 13 patients
26. T cell lymphoma occurring in Sjögren's syndrome
27. T cell lymphoma in a patient with longstanding rheumatoid arthritis and Sjögren's syndrome
28. Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjögren's syndome
29. Sjögren's syndrome and pleomorphic T-cell lymphoma presenting with skin involvement
30. Sjögren's syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma
31. Hodgkin's disease occurring in primary Sjögren's syndrome
32. Development of Hodgkin's disease in the course of primary Sjögren's syndrome
33. Chronic myelomonocytic leukemia and primary Sjögren's syndrome
34. Sjögren's syndrome terminating in multiple myeloma
35. Extra salivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma", and macroglobulinemia)
36. Predictors of lymphoma development in primary Sjögren's syndrome
37. Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's syndrome
38. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome
39. Lymphoma in Sjögren's syndrome. From histopathology to molecular pathology
40. Beta-2microglobulin and lymphocytic infiltration in Sjögren's syndrome
41. The occurrence of renal involvement in primary Sjögren's syndrome: A study of 78 patients
42. Survivorship in a population based cohort of patients with Sjögren's syndrome